tirzepatide rash treatment does cause rashes & The Relationship Between Obesity & Skin Issues Hives – Skin & Laser – Allergic Reaction to Zepbound: Signs,

J Intellect Disabil Res 2005

Tirzepatide: Another Relevant Comparison Tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 agonist approved by the FDA, provides another useful reference point

Furthermore, exploring metabolic differences between sexes may clarify the observed gender-specific expression patterns and support personalized diagnostic or therapeutic approaches

(2021) reported an EGFR-mutant lung cancer patient who developed SJS/TEN and hepatic injury after sequential PD-1 blockade and subsequent osimertinib therapy, supporting the concept that ICIs can create an immune-susceptible or low-threshold background predisposing to severe toxicity from later drugs